Skip to content
MedsAcross

Medicine

Isosorbide dinitrate 40 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Isosorbide dinitrate 40 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). Protect from Light.

Key facts

Active ingredient (INN)
Isosorbide dinitrate
Brand
Sold under the generic name
Strength
40 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets and 4 more
Manufacturers
Zydus LifesciencesIndiaAdvagen PharmaBryant Ranch PrepackOceanside PharmaceuticalsPar Health
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). Protect from Light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C01DA08 Isosorbide dinitrate
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
25 November 2019
Identifiers
RxCUI 197839, 197840, 206842 +2DailyMed set ID 5b0db8af-bcf9-458f-b752-420130cba428, 16818b32-ee5e-4e07-b848-31e892c4b98a, 3d6164d7-3083-41c5-a6a6-7e144fe29f7d +2NDC 70771-1505, 70710-1152, 63629-9593 +3Application ANDA213057, ANDA211290, NDA012093 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle70710-1152-1Zydus LifesciencesIndia25 November 2019
100 tablet in 1 bottle70771-1505-1Zydus LifesciencesIndia25 November 2019
1000 tablet in 1 bottle72888-085-00Advagen Pharma8 July 2022
100 tablet in 1 bottle72888-085-01Advagen Pharma8 July 2022
100 tablet in 1 bottle68682-192-01Oceanside Pharmaceuticals2 March 2020
100 tablet in 1 bottle49884-556-01Par Health21 December 2021
100 tablet in 1 bottle63629-9593-1Bryant Ranch Prepack21 December 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 9 November 1959Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Isosorbide dinitrate

Clinical summary

Isosorbide dinitrate is a nitrate vasodilator indicated for the prevention of angina pectoris due to coronary artery disease. It is available as tablets for oral use. MedsAcross supplies Isosorbide dinitrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Isosorbide dinitrate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Isosorbide dinitrate 40 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.